908 Devices INC Form 4 insider transactions

Christopher D. Brown, a Director of 908 Devices Inc., sold 17,800 shares of common stock on August 10, 2026.

Kevin J. Knopp, President and CEO and a Director of 908 Devices Inc., sold 149,013 shares of common stock on August 10, 2026.

Christopher D. Brown, a Director of 908 Devices Inc., sold 20,000 shares of common stock on August 5, 2026 for $8.49 per share.

AWM Investment Company, Inc. reported changes in beneficial ownership of 908 Devices Inc. common stock on August 4, 2026.

Kevin J. Knopp, President and CEO of 908 Devices Inc., reported the sale of 222 shares of common stock for $9.07 per share, executed under a pre-arranged Rule 10b5-1 trading plan.

Director Christopher D. Brown of 908 Devices Inc. sold 2,200 shares of common stock for an average price of $9.02, as part of a pre-arranged trading plan.

Christopher D. Brown, a Director at 908 Devices Inc., reported the sale of 20,000 shares of common stock for $8.84 per share, executed under a pre-arranged Rule 10b5-1 trading plan.

Kevin J. Knopp, President and CEO of 908 Devices Inc., reported the sale of 2,798 shares of common stock for $9.09 per share, executed under a pre-arranged Rule 10b5-1 trading plan.

Christopher D. Brown, a Director at 908 Devices Inc., has sold 9,900 shares of common stock for approximately $9.04 per share, as part of a pre-arranged trading plan.

Kevin J. Knopp, President and CEO of 908 Devices Inc., reported the sale of company stock totaling over 60,000 shares across three days in late June 2026, executed under a pre-established 10b5-1 trading plan.

Michele M. Leonhart, a Director at 908 Devices Inc., acquired 6,486 shares of common stock through the vesting of Restricted Stock Units.

AWM Investment Company, Inc. has reported transactions involving 908 Devices Inc. common stock, detailing acquisitions and beneficial ownership.

Director Brandi C. Vann was granted 13,656 restricted stock units and 6,209 stock options as part of standard equity compensation.

Director Michele Leonhart acquired 14,083 shares of 908 Devices Inc. through RSU vesting and received new equity grants.

Director E. Kevin Hrusovsky reported the vesting of restricted stock units and the acquisition of new equity awards in 908 Devices Inc.

Director Anthony Hunt acquired 14,083 shares through RSU vesting and received new equity grants as part of annual compensation.

Director Fenel M. Eloi reported the vesting of restricted stock units and the receipt of new equity grants in 908 Devices Inc.

Director Keith Crandell reported the vesting of restricted stock units and the acquisition of new equity awards in 908 Devices Inc.

Director Mark Spoto reported the vesting of restricted stock units and the acquisition of new equity awards in 908 Devices Inc.

Director Christopher D. Brown sold 100 shares of 908 Devices Inc. (MASS) common stock on June 4, 2026.

AWM Investment Company, Inc. reported the sale of 42,282 shares of 908 Devices Inc. common stock across two transactions in June 2026.

Christopher D. Brown, a Director at 908 Devices Inc., reported the sale of 20,000 shares of common stock for $8.73 per share, executed under a pre-arranged Rule 10b5-1 trading plan.

AWM Investment Company, Inc. reported the sale of 186,942 shares of 908 Devices Inc. common stock across multiple transactions.

CFO Joseph H. Griffith IV sold 6,940 shares of 908 Devices Inc. common stock under a pre-established Rule 10b5-1 trading plan.

908 Devices Inc. Director Christopher D. Brown sold 30,000 shares of common stock via a pre-arranged Rule 10b5-1 trading plan.

AWM Investment Company, Inc., a 10% owner of 908 Devices Inc., reported the sale of 5,000 shares of common stock at a weighted average price of $8.2514.

John Kenneweg, SVP of Sales & Product Marketing at 908 Devices Inc., reported a sale of 18,255 shares of common stock.

AWM Investment Company, Inc. reported the sale of 78,209 shares of 908 Devices Inc. across three trading days in May 2026.

Christopher D. Brown, a Director at 908 Devices Inc., reported the sale of 20,000 shares of common stock for $7.23 per share, executed under a pre-arranged Rule 10b5-1 trading plan.

John Kenneweg, SVP of Sales & Product Marketing at 908 Devices Inc., sold 7,787 shares to cover tax obligations upon vesting of performance stock units.